EUVIMEDEUVIMED entdecken
Klinische Studie (Phase I)Randomisierte kontrollierte Studie

Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension

Akshay S Desai, David J Webb, Jorg Taubel, Sarah Casey, Yansong Cheng, Gabriel J Robbie, Don Foster, Stephen A Huang, Sean Rhyee, Marianne T Sweetser, George L Bakris iD

New England Journal of Medicine · 20.07.2023 · 389 (3) · 228-238

DOI: 10.1056/nejmoa2208391 ↗

Kurz gefasst

Klinische Studie (Phase I) in der Zeitschrift New England Journal of Medicine, erschienen am 20.07.2023. Verfasst von Akshay S Desai und 10 weiteren Autor:innen. Beteiligte Einrichtung: From the Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (A.S.D.), and Alnylam Pharmaceuticals, Cambridge (Y.C., G.J.R., D.…. Hauptthemen laut MEDLINE: Angiotensinogen, Antihypertensive Agents, Hypertension. Die Arbeit wurde bisher 303-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Alnylam Pharmaceuticals.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AngiotensinogenAntihypertensive AgentsHypertensionHumansBlood PressureBlood Pressure Monitoring, AmbulatoryDouble-Blind MethodIrbesartanRNA InterferenceTetrazolesDietInjections, Subcutaneous

Substanzen

AngiotensinogenAntihypertensive AgentsIrbesartanTetrazoles

Autor:innen und Institutionen

  • From the Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (A.S.D.), and Alnylam Pharmaceuticals, Cambridge (Y.C., G.J.R., D.F., S.A.H., S.R., M.T.S.) - both in Massachusetts; the Centre for Card…

ORCID-Profile: George L Bakris

Förderung

  • Alnylam Pharmaceuticals

Zitieren

APA

Desai, A. S., Webb, D. J., Taubel, J., Casey, S., Cheng, Y., Robbie, G. J., Foster, D., Huang, S. A., Rhyee, S., Sweetser, M. T., & Bakris, G. L. (2023). Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension. New England Journal of Medicine, 389(3), 228-238. https://doi.org/10.1056/nejmoa2208391

Vancouver

Desai AS, Webb DJ, Taubel J, Casey S, Cheng Y, Robbie GJ, et al. Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension. New England Journal of Medicine. 2023;389(3):228-238. doi:10.1056/nejmoa2208391

BibTeX
@article{Desai2023,
  author = {Desai, Akshay S and Webb, David J and Taubel, Jorg and Casey, Sarah and Cheng, Yansong and Robbie, Gabriel J and Foster, Don and Huang, Stephen A and Rhyee, Sean and Sweetser, Marianne T and Bakris, George L},
  title = {Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension},
  journal = {New England Journal of Medicine},
  year = {2023},
  volume = {389},
  number = {3},
  pages = {228--238},
  doi = {10.1056/nejmoa2208391}
}
Kostenlos starten →